Joanne Jenkins Lager's most recent trade in ITeos Therapeutics Inc was a trade of 130,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on March 9, 2023.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
ITeos Therapeutics Inc | Joanne Jenkins Lager | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2023 | 130,000 | 130,000 | - | - | Stock Option (Right to Buy) | |
ITeos Therapeutics Inc | Joanne Jenkins Lager | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2022 | 85,000 | 85,000 | - | - | Stock Option (Right to Buy) | |
ITeos Therapeutics Inc | Joanne Jenkins Lager | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.30 per share. | 11 Mar 2022 | 3,500 | 3,500 | - | 4.3 | 15,050 | Common Stock |
ITeos Therapeutics Inc | Joanne Jenkins Lager | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 36.01 per share. | 11 Mar 2022 | 3,500 | 0 | - | 36.0 | 126,035 | Common Stock |
ITeos Therapeutics Inc | Joanne Jenkins Lager | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Mar 2022 | 3,500 | 178,938 | - | - | Stock Option (Right to Buy) | |
ITeos Therapeutics Inc | Joanne Jenkins Lager | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.30 per share. | 11 Feb 2022 | 3,500 | 3,500 | - | 4.3 | 15,050 | Common Stock |
ITeos Therapeutics Inc | Joanne Jenkins Lager | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2022 | 3,500 | 182,438 | - | - | Stock Option (right to buy) | |
ITeos Therapeutics Inc | Joanne Jenkins Lager | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 35.52 per share. | 11 Feb 2022 | 1,982 | 1,518 | - | 35.5 | 70,401 | Common Stock |
ITeos Therapeutics Inc | Joanne Jenkins Lager | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 36.27 per share. | 11 Feb 2022 | 1,518 | 0 | - | 36.3 | 55,058 | Common Stock |
ITeos Therapeutics Inc | Joanne Jenkins Lager | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jan 2022 | 3,500 | 185,938 | - | - | Stock Option (Right to Buy) | |
ITeos Therapeutics Inc | Joanne Jenkins Lager | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.30 per share. | 14 Jan 2022 | 3,500 | 3,500 | - | 4.3 | 15,050 | Common Stock |
ITeos Therapeutics Inc | Joanne Jenkins Lager | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 39.25 per share. | 14 Jan 2022 | 2,777 | 723 | - | 39.2 | 108,997 | Common Stock |
ITeos Therapeutics Inc | Joanne Jenkins Lager | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 39.58 per share. | 14 Jan 2022 | 723 | 0 | - | 39.6 | 28,616 | Common Stock |
ITeos Therapeutics Inc | Joanne Jenkins Lager | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 51.90 per share. | 03 Jan 2022 | 7,000 | 0 | - | 51.9 | 363,300 | Common Stock |
ITeos Therapeutics Inc | Joanne Jenkins Lager | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2022 | 7,000 | 189,438 | - | - | Stock Option (Right to Buy) | |
ITeos Therapeutics Inc | Joanne Jenkins Lager | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.30 per share. | 03 Jan 2022 | 7,000 | 7,000 | - | 4.3 | 30,100 | Common Stock |
ITeos Therapeutics Inc | Joanne Jenkins Lager | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 122,000 | 122,000 | - | - | Stock Option (Right to Buy) |